Raremark® has announced it is rebranding as Xperiome™ to better refine and enhance its offering to patients and the pharma industry as it enters into its next phase of growth. Xperiome will now become the name and corporate identity of the company, while the Raremark brand will solely represent its patient-facing activities dedicated to helping people better understand, talk about and manage rare diseases.
“Strategically, we are rebranding because we have two very different audiences, with individual needs that will benefit from equal attention and focus. Our members will continue to see the Raremark brand they have grown to know and trust, while Xperiome will lead as our corporate entity and industry-facing brand. This reboot is an exciting step that will enable us to continue providing a truly valuable experience for our members, while driving growth for Xperiome within the industry,” Jeremy Edwards, CEO of Xperiome, said.
As part of the rebrand, Raremark will expand to become a knowledge bank for the lived experience of rare disease to help people living with any of the 7,000+ known rare conditions.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
“Many experiences are shared across diverse conditions, such as the isolation of parenting a child with a disease many people don’t know about, or the frustration of not being taken seriously in the emergency room,” said Alex Garner, COO of Xperiome. “By taking down the fences conventionally put around health content, we are essentially setting it free so that anyone with any condition can access and find value from it. And we know access to information is a big challenge in rare disease.”